

Learn how Eohilia works to treat eosinophilic esophagitis. We explain its mechanism of action, how Budesonide reduces inflammation, and what to expect.
If your doctor has prescribed Eohilia for eosinophilic esophagitis (EoE), you might be wondering: how does this medication actually work? Understanding what Eohilia does inside your body can help you feel more confident about your treatment.
In this article, we'll break down Eohilia's mechanism of action in plain, easy-to-understand language.
To understand how Eohilia works, it helps to understand what's going wrong in your body when you have EoE.
Eosinophilic esophagitis is an allergic and immune-mediated condition. Here's the basic process:
Over time, if the inflammation isn't controlled, the esophagus can develop scar tissue and become permanently narrowed — a process called fibrosis. This is why treating EoE matters, even when symptoms seem manageable.
Eohilia's active ingredient is Budesonide, a synthetic corticosteroid. Corticosteroids are powerful anti-inflammatory medications that mimic cortisol, a hormone your body naturally produces.
Budesonide has been used in medicine for decades. You may have heard of it in other forms:
Eohilia is different because it's formulated as an oral suspension specifically designed to be swallowed and coat the esophagus. Other forms of Budesonide are designed for the lungs, nose, or intestines — not the esophagus.
Here's what happens when you take Eohilia:
Each dose is a 10 mL liquid packet containing 2 mg of Budesonide. When you swallow it, the suspension coats the inside of your esophagus. This is why you take it as a liquid rather than a pill — a pill would pass through too quickly to treat the esophageal lining.
The medication clings to the inflamed tissue in your esophagus. This is a topical approach — the drug works directly at the site of inflammation rather than traveling through your entire bloodstream first.
This is also why you shouldn't eat, drink, or brush your teeth for 30 minutes after taking Eohilia. Those actions could wash the medication away before it has time to work.
Once in contact with the esophageal tissue, Budesonide gets absorbed into the cells lining the esophagus. Inside these cells, it:
In simpler terms: Budesonide tells your immune system to calm down in the esophagus. It turns down the signals that were attracting all those eosinophils to the area.
With fewer signals calling them in, the number of eosinophils in your esophageal tissue drops. In clinical trials, Eohilia significantly reduced eosinophil counts in the esophagus after 12 weeks of treatment.
Fewer eosinophils means less inflammation, less damage, and improvement in your symptoms.
As inflammation decreases, your esophagus can begin to heal. Swelling goes down, the tissue becomes less stiff, and the esophagus can function more normally. Many patients notice:
You might wonder why your doctor prescribed a topical corticosteroid instead of a steroid pill like Prednisone. There's a good reason.
Oral steroid pills (systemic corticosteroids) affect your entire body. They're effective at reducing inflammation, but they come with significant side effects when used for more than a short period — weight gain, bone loss, high blood sugar, mood changes, and more.
Eohilia works topically. The Budesonide is designed to act locally in the esophagus and then get broken down quickly by the liver (a property called high first-pass metabolism). This means less of the drug enters your general circulation, which reduces the risk of body-wide steroid side effects.
That said, some Budesonide does get absorbed into your bloodstream. That's why side effects like adrenal suppression and immune suppression can still occur — they're just less likely than with systemic steroids.
Before Eohilia was approved, many EoE patients used a compounded budesonide slurry — Budesonide mixed with sucralose (Splenda) to create a sticky liquid. The principle was the same: coat the esophagus with a topical steroid.
Key differences:
Both approaches use the same active ingredient, but Eohilia offers the reliability of a standardized product.
Dupixent (dupilumab) is another FDA-approved treatment for EoE, but it works very differently:
Dupixent is significantly more expensive (around $3,700 per month) and is given by injection. Eohilia is a swallowed liquid. Your doctor will recommend the best option based on your specific situation, treatment history, and insurance coverage.
It's important to understand what Eohilia is and isn't:
Eohilia works by delivering Budesonide directly to your inflamed esophagus, calming the immune response that causes eosinophil buildup. It's a targeted, topical approach that reduces inflammation with fewer body-wide side effects than systemic steroids.
If you're starting Eohilia, be patient with the process — improvement takes weeks — and follow the dosing instructions carefully to get the most benefit. For more information, read our guides on Eohilia side effects and drug interactions to watch for.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.